Coxibs--beyond the GI tract: renal and cardiovascular issues (Q28195068)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12604156%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

review article

1 reference

title

Coxibs--beyond the GI tract: renal and cardiovascular issues (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12604156%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

1 reference

Anthony N DeMaria

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12604156%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

Matthew R Weir

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12604156%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

language of work or name

English

0 references

publication date

1 February 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12604156%20AND%20SRC:MED&resulttype=core&format=json

Journal of Pain and Symptom Management

31 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12604156%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12604156%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

issue

2 Suppl

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12604156%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

page(s)

S41-9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12604156%20AND%20SRC:MED&resulttype=core&format=json

Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group

31 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900630-9

7 January 2021

Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: A randomized controlled trial. Celecoxib Long-term Arthritis Safety Study

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900630-9

7 January 2021

A randomized trial comparing the effect of rofecoxib, a cyclooxygenase 2-specific inhibitor, with that of ibuprofen on the gastroduodenal mucosa of patients with osteoarthritis. Rofecoxib Osteoarthritis Endoscopy Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900630-9

7 January 2021

Adverse upper gastrointestinal effects of rofecoxib compared with NSAIDs

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900630-9

7 January 2021

Risk of cardiovascular events associated with selective COX-2 inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900630-9

7 January 2021

Effects of nonsteroidal anti-inflammatory drugs on prostaglandins and renal function

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900630-9

7 January 2021

Cyclooxygenase-1 and -2-dependent prostacyclin formation in patients with atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900630-9

7 January 2021

Immunolocalization of cyclooxygenase-2 in the macula densa of human elderly

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900630-9

7 January 2021

The macula densa is worth its salt

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900630-9

7 January 2021

Effects of nonsteroidal anti-inflammatory drugs on renal function: focus on cyclooxygenase-2-selective inhibition

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900630-9

7 January 2021

Nonsteroidal anti-inflammatory drugs: effects on kidney function

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900630-9

7 January 2021

Renal effects of selective cyclooxygenase-2 inhibition in normotensive salt-depleted subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900630-9

7 January 2021

Effects of celecoxib and naproxen on renal function in the elderly

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900630-9

7 January 2021

Effect of cyclooxygenase-2 inhibition on renal function in elderly persons receiving a low-salt diet. A randomized, controlled trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900630-9

7 January 2021

A meta-analysis of the effects of nonsteroidal anti-inflammatory drugs on blood pressure

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900630-9

7 January 2021

Do nonsteroidal anti-inflammatory drugs affect blood pressure? A meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900630-9

7 January 2021

Nonsteroidal anti-inflammatory drugs and blood pressure in an elderly population

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900630-9

7 January 2021

Propranolol increases prostacyclin synthesis in patients with essential hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900630-9

7 January 2021

The effects of nonsteroidal anti-inflammatory drugs on blood pressures of patients with hypertension controlled by verapamil

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900630-9

7 January 2021

Influence of non-steroidal anti-inflammatory drugs on renal function and 24h ambulatory blood pressure-reducing effects of enalapril and nifedipine gastrointestinal therapeutic system in hypertensive patients

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900630-9

7 January 2021

Effect of indomethacin on blood pressure in elderly people with essential hypertension well controlled on amlodipine or enalapril

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900630-9

7 January 2021

Effect of indomethacin on blood pressure lowering by captopril and losartan in hypertensive patients

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900630-9

7 January 2021

Rofecoxib, a specific inhibitor of cyclooxygenase 2, with clinical efficacy comparable with that of diclofenac sodium: results of a one-year, randomized, clinical trial in patients with osteoarthritis of the knee and hip. Rofecoxib Phase III Protoco

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900630-9

7 January 2021

Cyclooxygenase-2--specific inhibitors and cardiorenal function: a randomized, controlled trial of celecoxib and rofecoxib in older hypertensive osteoarthritis patients

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900630-9

7 January 2021

The mortality of rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900630-9

7 January 2021

Inflammation and coronary heart disease: an overview

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900630-9

7 January 2021

Inflammation and thrombosis: the clot thickens

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900630-9

7 January 2021

Nonsteroidal anti-inflammatory drug use and acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900630-9

7 January 2021

Lower risk of thromboembolic cardiovascular events with naproxen among patients with rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900630-9

7 January 2021

Association between naproxen use and protection against acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900630-9

7 January 2021

Selective COX-2 Inhibitors, NSAIDs, aspirin, and myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900630-9

7 January 2021

RANDOMISED TRIAL OF INTRAVENOUS STREPTOKINASE, ORAL ASPIRIN, BOTH, OR NEITHER AMONG 17 187 CASES OF SUSPECTED ACUTE MYOCARDIAL INFARCTION: ISIS-2

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900630-9

7 January 2021

Cardiovascular thrombotic events in controlled, clinical trials of rofecoxib

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900630-9

7 January 2021

Systemic biosynthesis of prostacyclin by cyclooxygenase (COX)-2: the human pharmacology of a selective inhibitor of COX-2

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900630-9

7 January 2021

Altered pain perception and inflammatory response in mice lacking prostacyclin receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900630-9

7 January 2021

Risk of gastrointestinal haemorrhage with long term use of aspirin: meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900630-9

7 January 2021

10.1016/S0885-3924(02)00630-9

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12604156%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12604156%20AND%20SRC:MED&resulttype=core&format=json